Astley-Sparke Philip
SEC CIK 1376491 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Executive COB, Dir | 1.36M | — | $1.06M | 11 | 2022-04-01 | 2026-08-20 |
Most active insiders at REPL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sushil | CEO, Dir | — | $811.2K |
| 2 | Hill Emily Luisa | CFO | — | $320.3K |
| 3 | Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| 4 | Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| 5 | Schwendenman Andrew | CAO | — | $139.1K |
| 6 | Astley-Sparke Philip | Dir | — | $89.7K |
| 7 | Dhingra Kapil | Dir | — | $33.0K |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 19:48 | 2026-08-20 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | Dir | G - Gift | $0.00 | -50.0K | 1.36M | -4% | $0 | |
| 2026-05-20 16:16 | 2026-05-18 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | Dir | S - Sale | $5.08 | -17.7K | 1.41M | -1% | -$89.7K | |
| D | 2026-04-07 21:10 | 2026-04-01 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | Dir | A - Grant | $0.00 | +50.0K | 1.43M | +4% | $0 |
| 2026-02-20 | 2026-02-18 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | Dir | G - Gift | $0.00 | -25.0K | 1.38M | -2% | $0 | |
| 2025-05-22 | 2025-05-20 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | Dir | S - Sale | $8.06 | -32.3K | 1.41M | -2% | -$260.2K | |
| 2024-08-30 | 2024-08-30 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | Executive COB, Dir | G - Gift | $0.00 | -50.0K | 1.44M | -3% | $0 | |
| 2024-05-20 | 2024-05-16 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | Executive COB, Dir | S - Sale | $6.47 | -37.9K | 1.49M | -2% | -$245.4K | |
| 2023-05-18 | 2023-05-16 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | CEO, Dir | S - Sale | $18.05 | -17.9K | 1.53M | -1% | -$323.1K | |
| D | 2023-04-04 | 2023-04-01 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | CEO, Dir | A - Grant | $0.00 | +142.1K | 1.54M | +10% | $0 |
| 2022-05-18 | 2022-05-16 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | CEO, Dir | S - Sale | $14.59 | -9,632 | 1.40M | -0.7% | -$140.5K | |
| D | 2022-04-05 | 2022-04-01 | REPL | Replimune Group, Inc. | Astley-Sparke Philip | CEO, Dir | A - Grant | $0.00 | +70.0K | 1.41M | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations